U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT06893861) titled 'Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer' on March 18.
Brief Summary: The study involves the use of reagents or materials for diagnostic assessments that are not commercially available, specifically a metabolomic signature for screening endometrial carcinoma and/or other types of cancers, and follows a case-control design.
This study aims to achieve several objectives that contribute to evaluating the diagnostic potential of a specific "metabolomic signature" to be used for screening endometrial carcinoma. Specifically, the study seeks to assess the signature's discriminative ...